Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Arcadia Biosciences (RKDA) Return on Invested Capital (2016 - 2024)

Arcadia Biosciences' Return on Invested Capital history spans 10 years, with the latest figure at 0.45% for Q4 2024.

  • For Q4 2024, Return on Invested Capital rose 12.0% year-over-year to 0.45%; the TTM value through Dec 2024 reached 0.45%, up 12.0%, while the annual FY2025 figure was 0.48%, 10.0% down from the prior year.
  • Return on Invested Capital reached 0.45% in Q4 2024 per RKDA's latest filing, down from 0.24% in the prior quarter.
  • In the past five years, Return on Invested Capital ranged from a high of 0.1% in Q3 2021 to a low of 2.19% in Q3 2020.
  • Average Return on Invested Capital over 5 years is 0.76%, with a median of 0.69% recorded in 2023.
  • Peak YoY movement for Return on Invested Capital: soared 253bps in 2020, then crashed -95bps in 2022.
  • A 5-year view of Return on Invested Capital shows it stood at 0.02% in 2020, then tumbled by -2136bps to 0.54% in 2021, then plummeted by -36bps to 0.74% in 2022, then increased by 23bps to 0.57% in 2023, then increased by 22bps to 0.45% in 2024.
  • Per Business Quant, the three most recent readings for RKDA's Return on Invested Capital are 0.45% (Q4 2024), 0.24% (Q3 2024), and 0.2% (Q2 2024).